By Seth Borenstein

Astronomers have found a potential sign of life high in the atmosphere of neighboring Venus: hints there may be bizarre microbes living in the sulfuric acid-laden clouds of the hothouse planet.

Two telescopes in Hawaii and Chile spotted in the thick Venusian clouds the chemical signature of phosphine, a noxious gas that on Earth is only associated with life, according to a study in Monday’s journal Nature Astronomy.

Several outside experts — and the study authors themselves — agreed this is tantalizing but said it is far from the first proof of life on another planet. They said it doesn't satisfy the “extraordinary claims require extraordinary evidence" standard established by the late Carl Sagan, who speculated about the possibility of life in the clouds of Venus in 1967.

“It’s not a smoking gun," said study co-author David Clements, an Imperial College of London astrophysicist. “It’s not even gunshot residue on the hands of your prime suspect, but there is a distinct whiff of cordite in the air which may be suggesting something.”

As astronomers plan for searches for life on planets outside our solar system, a major method is to look for chemical signatures that can only be made by biological processes, called biosignatures. After three astronomers met in a bar in Hawaii, they decided to look that way at the closest planet to Earth: Venus. They searched for phosphine, which is three hydrogen atoms and a phosphorous atom.

On Earth, there are only two ways phosphine can be formed, study authors said. One is in an industrial process. (The gas was produced for use as chemical warfare agent in World War I.) The other way is as part of some kind of poorly understood function in animals and microbes. Some scientists consider it a waste product, others don't.

Phosphine is found in “ooze at the bottom of ponds, the guts of some creatures like badgers and perhaps most unpleasantly associated with piles of penguin guano,” Clements said.

Study co-author Sara Seager, an MIT planetary scientist, said researchers “exhaustively went through every possibility and ruled all of them out: volcanoes, lightning strikes, small meteorites falling into the atmosphere. ... Not a single process we looked at could produce phosphine in high enough quantities to explain our team’s findings.”

That leaves life.

The astronomers hypothesize a scenario for how life could exist on the inhospitable planet where temperatures on the surface are around 800 degrees (425 degrees Celsius) with no water.

“Venus is hell. Venus is kind of Earth’s evil twin,” Clements said. “Clearly something has gone wrong, very wrong, with Venus. It’s the victim of a runaway greenhouse effect.”

But that’s on the surface.

Seager said all the action may be 30 miles (50 kilometers) above ground in the thick carbon-dioxide layer cloud deck, where it's about room temperature or slightly warmer. It contains droplets with tiny amounts of water but mostly sulfuric acid that is a billion times more acidic than what’s found on Earth.

The phosphine could be coming from some kind of microbes, probably single-cell ones, inside those sulfuric acid droplets, living their entire lives in the 10-mile-deep (16-kilometer-deep) clouds, Seager and Clements said. When the droplets fall, the potential life probably dries out and could then get picked up in another drop and reanimate, they said.

Life is definitely a possibility, but more proof is needed, several outside scientists said.

Cornell University astronomer Lisa Kaltenegger said the idea of this being the signature of biology at work is exciting, but she said we don’t know enough about Venus to say life is the only explanation for the phosphine.

“I’m not skeptical, I’m hesitant,” said Justin Filiberto, a planetary geochemist at the Lunar and Planetary Institute in Houston who specializes in Venus and Mars and isn’t part of the study team.

Filiberto said the levels of phosphine found might be explained away by volcanoes. He said recent studies that were not taken into account in this latest research suggest that Venus may have far more active volcanoes than originally thought. But Clements said that explanation would make sense only if Venus were at least 200 times as volcanically active as Earth.

David Grinspoon, a Washington-based astrobiologist at the Planetary Science Institute who wrote a 1997 book suggesting Venus could harbor life, said the finding “almost seems too good to be true.”

“I’m excited, but I’m also cautious,” Grinspoon said. “We found an encouraging sign that demands we follow up.”

NASA hasn’t sent anything to Venus since 1989, though Russia, Europe and Japan have dispatched probes. The U.S. space agency is considering two possible Venus missions. One of them, called DAVINCI+, would go into the Venusian atmosphere as early as 2026.

Clements said his head tells him “it’s probably a 10% chance that it’s life,” but his heart "obviously wants it to be much bigger because it would be so exciting.”

___

Follow Seth Borenstein on Twitter: @borenbears

___

The Associated Press Health & Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Share:
More In Science
FDA Authorizes Pfizer's Covid-19 Treatment Pill Marking Pandemic Milestone
The FDA has granted emergency use authorization to Pfizer's pill to treat covid-19. The treatment, called Paxlovid, is the first antiviral covid-19 pill that people can take at home. Pfizer says the pill can reduce the risk of severe illness by 90 percent and is intended for people at high risk for severe disease, including those over 65, people with obesity, diabetes, or a weakened immune system. Professor Peter Pitts, Founder, Center for Medicine in the Public Interest & Former FDA Associate joined Wake Up with Cheddar to discuss.
Markets Continue to Feel Omicron Pressures
Ahead of a four day week for the markets due to the upcoming Christmas holiday, investors hoping for a quiet end to the year, or even a Santa Claus rally, may not be in luck. Investors are still digesting the latest from the Fed regarding a quicker than expected taper, as well as ever increasing blow back as the Omicron variant spreads. Octavio Marenzi, CEO of Opimas LLC, explains why the markets have been so volatile ever since the emergence of the latest variant and what to expect going forward into 2022.
An Omicron Christmas, Student Loans & Love, Hate, Ate
Carlo and Baker cover the heartening news on the Covid front ahead of the holiday, plus President Biden punting student loan repayments again, a new space telescope and Love, Hate, Ate: Christmas Eve Eve Edition!
Pfizer COVID Treatment Pill Gets FDA Authorization
Pfizer, one of the makers of a currently available COVID-19 vaccine, has taken another critical step forward in combatting the pandemic by getting regulatory approval for Paxlovid, a pill treatment rather than IV or injection as others have been. Dr. Purvi Parikh, an immunologist with the Allergy and Asthma Network, spoke to Cheddar about the ramifications of the authorization. "This is huge, especially because we know early treatment does keep people out of the hospital, especially with this antiviral," Parikh said. "The fact that people can start a regimen at home so they don't have to leave and further expose others is a big breakthrough." She also explained how the drug is a combination of two antiviral medications that are not without its risks but should be safe over the short term.
Semiconductor Industry Warns Shortage Could Last Deep Into 2022
This year's worldwide semiconductor shortage limited the supply of everything from new cars to smartphones; and now, many in the chip industry expect the shortage to continue deep into 2022, and maybe even 2023. Semiconductor senior research analyst for Robert W. Baird & Co., Tristan Gerra, joins Cheddar News' Closing Bell to discuss.
Nomi Health Closes $110 Million to Further Scale Its Direct Healthcare Model Nationwide
Direct health care company Nomi Health recently raised $110 million in a Series A round. Nomi Health lets public and private organizations directly purchase healthcare at reduced costs, and pay providers in real-time. It also delivers healthcare directly to under-served communities via its fleet of mobile care units, which the company says is the largest in the country. Nomi Health says its mission is to improve the health care experience for all Americans. Nomi Health CEO Mark Newman joined Cheddar News' Closing Bell to discuss.
Delta Airlines CEO Calls for Shortened Quarantine Times Amid Staffing Shortage
The airline industry says it is contending with staff shortages that threaten to hamper operations amid the COVID resurgence, andDelta Airlines CEO Ed Bastian called on the CDC to revise its guidance for vaccinated workers who test positive from a 10-day quarantine to just five. Chuck Liberman, chief investment officer and managing partner at Advisors Capital Management LLC, joined Cheddar to talk about the current guidance on isolation and why he believes the omicron variant calls for more relaxed guidance given its reportedly mild symptoms.
NASA to Launch The James Webb Space Telescope on Christmas Eve
NASA is launching its new generation of space telescopes just before Christmas. The James Webb Space Telescope, set to launch on December 24th, will succeed the Hubble space telescope as the world's most powerful complex space observatory. The project has been 30 years in the making and is one of the most highly anticipated space science missions of the 21st century. Klaus Pontoppidan, astronomer and JWST Project Scientist at the Space Telescope Science Institute joined Cheddar's Opening Bell to discuss.
The Importance of COVID-19 Tests in the Age of Omicron
With Omicron becoming the dominant COVID-19 variant in the U.S., President Joe Biden announced that he will make 500 million rapid tests available to Americans in January 2022. Cheddar News speaks with Dr. Shereef Elnahal, President and CEO of University Hospital why testing is key to combatting the spread of the virus.
Load More